Add Yahoo as a preferred source to see more of our stories on Google. This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with ...
A team at Stanford Medicine has delivered something people with Type 1 diabetes have waited decades to hear: a cure in animals that does not rely on toxic chemotherapy or lifelong immune drugs. In ...
A specially devised hybrid treatment has shown tremendous potential for treating type 1 diabetes in mice, scoring full marks at preventing the condition in prediabetic animals and at reversing the ...
For more than a hundred years, insulin has been the key to controlling type 1 diabetes. It has saved lives by preventing diabetic ketoacidosis (DKA), a life-threatening condition that happens when the ...
A stem cell trial on a dozen Type 1 diabetes patients suffering from a severe form of the disease has provided at least a temporary cure for 10 participants. The remaining two also dramatically ...
Each November, we observe National Diabetes Month and engage in discussions surrounding prevention, management and the impact of this increasingly common autoimmune disease. Diabetes, both type 1 and ...
New fundraising campaign will catalyze larger, higher-conviction investments to bolster promising T1D programs, leveraging the Fund's strong track-record and management team Led by a $12 million ...
In under eight weeks, SANA has nearly tripled, reflecting a shift from speculative promise to emerging proof-of-concept. If you sized SANA small after the May post, the thesis is tracking; consider ...
This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results